214 related articles for article (PubMed ID: 38693312)
1. Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells.
Favaretto G; Rossi MN; Cuollo L; Laffranchi M; Cervelli M; Soriani A; Sozzani S; Santoni A; Antonangeli F
Cancer Immunol Immunother; 2024 May; 73(6):113. PubMed ID: 38693312
[TBL] [Abstract][Full Text] [Related]
2. Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells.
Maskey RS; Wang F; Lehman E; Wang Y; Emmanuel N; Zhong W; Jin G; Abraham RT; Arndt KT; Myers JS; Mazurek A
Cell Cycle; 2021 Jan; 20(1):65-80. PubMed ID: 33356791
[TBL] [Abstract][Full Text] [Related]
3. Palbociclib Effectively Halts Proliferation but Fails to Induce Senescence in Patient-Derived Glioma Stem Cells.
Morris-Hanon O; Marazita MC; Romorini L; Isaja L; Fernandez-Espinosa DD; Sevlever GE; Scassa ME; Videla-Richardson GA
Mol Neurobiol; 2019 Nov; 56(11):7810-7821. PubMed ID: 31124078
[TBL] [Abstract][Full Text] [Related]
4. Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth.
Guan X; LaPak KM; Hennessey RC; Yu CY; Shakya R; Zhang J; Burd CE
Mol Cancer Res; 2017 Mar; 15(3):237-249. PubMed ID: 28039358
[TBL] [Abstract][Full Text] [Related]
5. SASP-Dependent Interactions between Senescent Cells and Platelets Modulate Migration and Invasion of Cancer Cells.
Valenzuela CA; Quintanilla R; Olate-Briones A; Venturini W; Mancilla D; Cayo A; Moore-Carrasco R; Brown NE
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653055
[TBL] [Abstract][Full Text] [Related]
6. Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib.
Miettinen TP; Peltier J; Härtlova A; Gierliński M; Jansen VM; Trost M; Björklund M
EMBO J; 2018 May; 37(10):. PubMed ID: 29669860
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence in the response of HR
Klapp V; Buqué A; Bloy N; Sato A; Yamazaki T; Zhou XK; Formenti SC; Galluzzi L; Petroni G
J Transl Med; 2023 Feb; 21(1):110. PubMed ID: 36765430
[TBL] [Abstract][Full Text] [Related]
8. Palbociclib-Induced Cellular Senescence Is Modulated by the mTOR Complex 1 and Autophagy.
Cayo A; Venturini W; Rebolledo-Mira D; Moore-Carrasco R; Herrada AA; Nova-Lamperti E; Valenzuela C; Brown NE
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298236
[TBL] [Abstract][Full Text] [Related]
9. Palbociclib-induced autophagy and senescence in gastric cancer cells.
Valenzuela CA; Vargas L; Martinez V; Bravo S; Brown NE
Exp Cell Res; 2017 Nov; 360(2):390-396. PubMed ID: 28947133
[TBL] [Abstract][Full Text] [Related]
10. Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.
Kishino E; Ogata R; Saitoh W; Koike Y; Ohta Y; Kanomata N; Kurebayashi J
Breast Cancer; 2020 May; 27(3):415-425. PubMed ID: 31823286
[TBL] [Abstract][Full Text] [Related]
11. Senescent Secretome of Blind Mole Rat
Odeh A; Eddini H; Shawasha L; Chaban A; Avivi A; Shams I; Manov I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982207
[TBL] [Abstract][Full Text] [Related]
12. Cellular senescence: from anti-cancer weapon to anti-aging target.
Yuan L; Alexander PB; Wang XF
Sci China Life Sci; 2020 Mar; 63(3):332-342. PubMed ID: 32060861
[TBL] [Abstract][Full Text] [Related]
13. Secretome of senescent hepatoma cells modulate immune cell fate by macrophage polarization and neutrophil extracellular traps formation.
Sen B; Aggarwal S; Nath R; Sehgal R; Singh R; Agrawal K; Shashidhara AN; Rastogi A; Bajpai M; Pamecha V; Trehanpati N; Ramakrishna G
Med Oncol; 2022 Jun; 39(9):134. PubMed ID: 35726030
[TBL] [Abstract][Full Text] [Related]
14. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
15. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
D'Ambrosio M; Gil J
Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
[TBL] [Abstract][Full Text] [Related]
16. Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.
Min A; Kim JE; Kim YJ; Lim JM; Kim S; Kim JW; Lee KH; Kim TY; Oh DY; Bang YJ; Im SA
Cancer Lett; 2018 Aug; 430():123-132. PubMed ID: 29729292
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells.
Hwang HJ; Lee YR; Kang D; Lee HC; Seo HR; Ryu JK; Kim YN; Ko YG; Park HJ; Lee JS
Cancer Lett; 2020 Oct; 490():100-110. PubMed ID: 32659248
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.
Wang D; Xiao F; Feng Z; Li M; Kong L; Huang L; Wei Y; Li H; Liu F; Zhang H; Zhang W
Breast Cancer Res; 2020 Sep; 22(1):103. PubMed ID: 32993785
[TBL] [Abstract][Full Text] [Related]
19. Targeting cellular senescence as a therapeutic vulnerability in gastric cancer.
Geng H; Huang C; Xu L; Zhou Y; Dong Z; Zhong Y; Li Q; Yang C; Huang S; Liao W; Lin Y; Liu Z; Li Q; Zhang Z; Zhu C
Life Sci; 2024 Jun; 346():122631. PubMed ID: 38621585
[TBL] [Abstract][Full Text] [Related]
20. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
